Redox Sensitivity of Tyrosine Hydroxylase Activity and Expression in Dopaminergic Dysfunction

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 11, Iss. 4, 2012-06 ,pp. : 419-429

Bentham Science Publishers

Access to resources Recommend Favorite

Ritanserin counteracts both rat vacuous chewing movements and nigro-striatal tyrosine hydroxylase-immunostaining alterations induced by haloperidol

By Marchese G.   Bartholini F.   Ruiu S.   Casti P.   Casu G.L.   Pani L.  

European Journal of Pharmacology, Vol. 483, Iss. 1, 2004-01 ,pp. : 65-69

Elsevier

Access to resources Recommend Favorite

Brain tyrosine depletion attenuates haloperidol-induced striatal dopamine release in vivo and augments haloperidol-induced catalepsy in the rat

By Jaskiw George   Bongiovanni Rodolfo  

Psychopharmacology, Vol. 172, Iss. 1, 2004-02 ,pp. : 100-107

Springer Publishing Company

Access to resources Recommend Favorite

Regulation of tyrosine hydroxylase and aromatic l-amino acid decarboxylase by dopaminergic drugs

By Cho S.   Neff N.H.   Hadjiconstantinou M.  

European Journal of Pharmacology, Vol. 323, Iss. 2, 1997-04 ,pp. : 149-157

Elsevier

Access to resources Recommend Favorite

A Current Review of Cypermethrin-Induced Neurotoxicity and Nigrostriatal Dopaminergic Neurodegeneration

By  

Current Neuropharmacology, Vol. 10, Iss. 1, 2012-03 ,pp. : 64-71

Bentham Science Publishers

Access to resources Recommend Favorite